This live session provides a focused overview of medical approaches to caring for patients with substance use disorders, emphasizing the integration of addiction treatment into healthcare settings and evidence-based strategies to improve patient outcomes.
What This Includes
• Integration of addiction treatment into inpatient and outpatient clinical settings• The intersection of substance use disorders and medical complications, including infectious diseases such as infective endocarditis and hepatitis C• Evidence-based strategies for initiating medications for opioid use disorder (MOUD)• Low-dose buprenorphine initiation in complex clinical scenarios• Multidisciplinary, hospital-based models of care for patients with substance use disorders• Harm reduction and prevention strategies that support engagement in treatment and improve outcomes
What to Expect
• Live, faculty-led instruction delivered in an interactive online format• Case-based discussion highlighting real-world challenges in integrating addiction treatment into medical care• Structured content aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas• Practical guidance for initiating and managing treatment in medically complex patients• Clinical strategies for improving care coordination, treatment engagement, and long-term outcomes across healthcare settings
Jeanette M. Tetrault, MD FACP FASAM
Dr. Tetrault is a Professor of Medicine and Epidemiology at Yale School of Medicine and serves as Program Director of the Addiction Medicine Fellowship. She also holds leadership roles in addiction medicine education and training within Yale’s Program in Addiction Medicine.
Her work focuses on improving care for patients with substance use disorders and associated medical conditions, including HIV and hepatitis C, as well as advancing addiction medicine education and curriculum development.
To support a meaningful learning experience and recognize your participation: